Literature DB >> 28564724

Epigenetics in the Primary Biliary Cholangitis and Primary Sclerosing Cholangitis.

Angela C Cheung1, Nicholas F LaRusso1, Gregory J Gores1, Konstantinos N Lazaridis1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28564724      PMCID： PMC5553635          DOI： 10.1055/s-0037-1603324

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN： 0272-8087            Impact factor:   6.115


× No keyword cloud information.
  130 in total

Review 1.  Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review.

Authors:  Kirsten Boonstra; Ulrich Beuers; Cyriel Y Ponsioen
Journal:  J Hepatol       Date:  2012-01-13       Impact factor: 25.083

Review 2.  Diet, the gut microbiome, and epigenetics.

Authors:  Meredith A J Hullar; Benjamin C Fu
Journal:  Cancer J       Date:  2014 May-Jun       Impact factor: 3.360

3.  Primary biliary cirrhosis.

Authors:  Keith D Lindor; M Eric Gershwin; Raoul Poupon; Marshall Kaplan; Nora V Bergasa; E Jenny Heathcote
Journal:  Hepatology       Date:  2009-07       Impact factor: 17.425

Review 4.  Identification and function of enhancers in the human genome.

Authors:  Candice J Coppola; Ryne C Ramaker; Eric M Mendenhall
Journal:  Hum Mol Genet       Date:  2016-07-08       Impact factor: 6.150

5.  Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients.

Authors:  M Eric Gershwin; Carlo Selmi; Howard J Worman; Ellen B Gold; Mitchell Watnik; Jessica Utts; Keith D Lindor; Marshall M Kaplan; John M Vierling
Journal:  Hepatology       Date:  2005-11       Impact factor: 17.425

Review 6.  Enhancer function: new insights into the regulation of tissue-specific gene expression.

Authors:  Chin-Tong Ong; Victor G Corces
Journal:  Nat Rev Genet       Date:  2011-03-01       Impact factor: 53.242

7.  Estimation of effect size distribution from genome-wide association studies and implications for future discoveries.

Authors:  Ju-Hyun Park; Sholom Wacholder; Mitchell H Gail; Ulrike Peters; Kevin B Jacobs; Stephen J Chanock; Nilanjan Chatterjee
Journal:  Nat Genet       Date:  2010-06-20       Impact factor: 38.330

Review 8.  Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature.

Authors:  Jason K Hou; Bincy Abraham; Hashem El-Serag
Journal:  Am J Gastroenterol       Date:  2011-04       Impact factor: 10.864

9.  Farnesoid X receptor-induced lysine-specific histone demethylase reduces hepatic bile acid levels and protects the liver against bile acid toxicity.

Authors:  Young-Chae Kim; Sungsoon Fang; Sangwon Byun; Sunmi Seok; Byron Kemper; Jongsook Kim Kemper
Journal:  Hepatology       Date:  2015-02-27       Impact factor: 17.425

10.  MicroRNA dynamics in the stages of tumorigenesis correlate with hallmark capabilities of cancer.

Authors:  Peter Olson; Jun Lu; Hao Zhang; Anny Shai; Matthew G Chun; Yucheng Wang; Steven K Libutti; Eric K Nakakura; Todd R Golub; Douglas Hanahan
Journal:  Genes Dev       Date:  2009-09-15       Impact factor: 11.361
View more
  8 in total

1.  Proteasomal Degradation of Enhancer of Zeste Homologue 2 in Cholangiocytes Promotes Biliary Fibrosis.

Authors:  Nidhi Jalan-Sakrikar; Thiago M De Assuncao; Guang Shi; Sayed Obaidullah Aseem; Cheng Chi; Vijay H Shah; Robert C Huebert
Journal:  Hepatology       Date:  2019-06-22       Impact factor: 17.425

Review 2.  Epigenetic Aspects and Prospects in Autoimmune Hepatitis.

Authors:  Albert J Czaja
Journal:  Front Immunol       Date:  2022-06-30       Impact factor: 8.786

Review 3.  Genetics and epigenetics in the pathogenesis of primary biliary cholangitis.

Authors:  Satoru Joshita; Takeji Umemura; Eiji Tanaka; Masao Ota
Journal:  Clin J Gastroenterol       Date:  2017-11-20

4.  Cholest-4,6-Dien-3-One Promote Epithelial-To-Mesenchymal Transition (EMT) in Biliary Tree Stem/Progenitor Cell Cultures In Vitro.

Authors:  Lorenzo Nevi; Daniele Costantini; Samira Safarikia; Sabina Di Matteo; Fabio Melandro; Pasquale Bartolomeo Berloco; Vincenzo Cardinale
Journal:  Cells       Date:  2019-11-15       Impact factor: 6.600

Review 5.  Epigenetic Modifications in Generalized Autoimmune Epithelitis: Sjögren's Syndrome and Primary Biliary Cholangitis.

Authors:  Pinelopi Arvaniti; Kalliopi Zachou; Aggeliki Lyberopoulou; Nikolaos K Gatselis; Wesley H Brooks; George N Dalekos; Yves Renaudineau
Journal:  Epigenomes       Date:  2019-08-08

6.  Epigenetic Signatures Discriminate Patients With Primary Sclerosing Cholangitis and Ulcerative Colitis From Patients With Ulcerative Colitis.

Authors:  Manon de Krijger; Ishtu L Hageman; Andrew Y F Li Yim; Jan Verhoeff; Juan J Garcia Vallejo; Patricia H P van Hamersveld; Evgeni Levin; Theodorus B M Hakvoort; Manon E Wildenberg; Peter Henneman; Cyriel Y Ponsioen; Wouter J de Jonge
Journal:  Front Immunol       Date:  2022-03-16       Impact factor: 7.561

7.  DNA methylation profile of liver tissue in end-stage cholestatic liver disease.

Authors:  Angela C Cheung; Brian D Juran; Erik M Schlicht; Bryan M McCauley; Elizabeth J Atkinson; Raymond Moore; Julie K Heimbach; Kymberly D Watt; Tsung-Teh Wu; Nicholas F LaRusso; Gregory J Gores; Zhifu Sun; Konstantinos N Lazaridis
Journal:  Epigenomics       Date:  2022-04-27       Impact factor: 4.357

8.  Genome-wide resolution peripheral blood methylome profiling reveals signatures for cholestatic liver disease.

Authors:  Raymond M Moore; Zhifu Sun; Brian D Juran; Konstantinos N Lazaridis
Journal:  Epigenomics       Date:  2020-09-11       Impact factor: 4.778
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.